Navigation Links
Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company
Date:3/17/2009

PITTSBURGH, March 17 /PRNewswire/ -- Cardiorobotics, Inc., a medical device company developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military, and law enforcement, announces the appointment of Dr. Samuel Straface in the position of President & Chief Executive Officer.

"We are excited that Dr. Straface has joined Cardiorobotics in this executive leadership role," stated Executive Chairman and founding CEO, David Wagner. "Dr. Straface's long track record of commercial success, exceptional management, interpersonal and organizational skills, along with a diverse industry background in biological sciences, surgical applications and medical devices will guide Cardiorobotics as we continue to develop into a world class company.

"This appointment reinforces Cardiorobotics' commitment to creating a medical device company that will be a leader in developing products to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, natural orifice and a range of single-port laparoscopic and thoracoscopic procedures," says Mr. Wagner.

Dr. Straface has joined the leadership team that includes the two company co-founders; Chief Technology Officer Howie Choset, Ph.D. and Chairman of the Scientific Advisory Board, Marco A. Zenati, M.D. "I am excited about joining the Cardiorobotics team and leading them through the company's first clinical trials and then commercialization for single port cardiac procedures," stated Dr. Straface.

Dr. Straface began working with Cardiorobotics as an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse (PLSG). "We are thrilled that the PLSG is able to assist in the commercialization of Cardiorobotics and help to facilitate the development of the leadership team," says John W. Manzetti, PLSG President & CEO. "Samuel has the back
'/>"/>

SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 02, 2015 Outside GC, the leading ... the addition of Debbie Casey as a member of ... healthcare space. , Debbie has spent over ... with Fresenius Medical Care North America in both legal ... experience to work with Outside GC’s growing list of ...
(Date:2/27/2015)... SUMMERLAND, British Columbia , Feb. 27, 2015 /PRNewswire/ ... a leader in synthetic biology, today announced it has ... (OSF), the pioneering agricultural company behind the ... apple. Through the acquisition, Intrexon expands its food programs ... and convenient for consumers while providing economic benefit throughout ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
(Date:2/27/2015)... Illinois (PRWEB) February 27, 2015 FamilyFarms ... Sims, General Manager of State Line Farms, received the ... recognizes a producer, under the age of 35, who ... "It is an honor to win the Tomorrow's Top ... discovering who won the Top Producer Award and learning ...
Breaking Biology Technology:Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... Biotest Pharmaceuticals,Corporation, a leading developer of ... management team as part of the formal,completion ... (Nasdaq:,NABI) and the creation of Biotest Pharmaceuticals. ... Corporation Completes Acquisition,of Nabi Biologics Business Unit," ...
... Biotest Pharmaceuticals,Corporation, a leading developer of immunology ... the acquisition of the Nabi,Biopharmaceuticals (Nasdaq: ... million,in cash. Biotest Pharmaceuticals is a wholly-owned ... of the Nabi Biologics product pipeline,(including Nabi-HB(R)), ...
... Provide Testing for Important Cancer and Leukemia Group ... ... Genetics,a business unit of Genzyme Corporation (Nasdaq: GENZ ), announced today ... National Cancer Institute. The multi-center study will include 1,700,newly diagnosed patients with ...
Cached Biology Technology:Biotest Pharmaceuticals Corporation Announces Management Team 2Biotest Pharmaceuticals Corporation Announces Management Team 3Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 2Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 3National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 2National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 3National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 4
(Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... MADISON, Wis. Transplantation of human stem cells in ... survival and muscle function in rats used to model ... muscles, causing death by respiratory failure. ALS (amyotrophic ... to the ALS Association, the condition strikes about 5,600 ...
... (May 27, 2013) A new study shows the ... significant spike in the number of young children treated ... "We have seen an increase in unintentional ingestions ... laws in Colorado," said George Wang, MD, lead author ...
... College researchers have identified a new regulator for plant hormone ... that may help to improve production of fruits, vegetables ... week of May 27 in the journal Proceedings of ... paper, titled "SCFKMD controls cytokinin signaling by regulating the degradation ...
Cached Biology News:Engineered stem cell advance points toward treatment for ALS 2Engineered stem cell advance points toward treatment for ALS 3Surge in children accidentally eating marijuana-laced foods 2Surge in children accidentally eating marijuana-laced foods 3KISS ME DEADLY proteins may help improve crop yields 2
... The EasyCount ViaSure Kit is used in ... and live nucleated cells automatically. The ViaSure ... acid dyes - Acridine Orange and Ethidium Bromide ... a single test, while the EasyCount Slide 6 ...
... SureLINK Bioconjugation Kit provides a powerful yet ... and nuceleic acids. The kit provides the ... reagents for quantifying conjugation efficiencies. It enables ... biotin and other tags with a variety ...
... Pierce offers maleimide activated carrier proteins ... conjugates. Imject Maleimide Activated Carrier Proteins ... been preactivated with a heterobifunctional cross-linker ... stable, sulfhydryl-reactive carrier protein. Thus ...
...
Biology Products: